Program (Tuesday July 1, 2014)

Print

Hall A
16:55
Welcome & Introduction
Session 1 17:00–18:00
BPH and 5 α-reductase inhibitors
Chairpersons: Mark Stovsky, USA & Dov Engelstein, Israel
17:00-17:20
Sympotomatic BPH: Who is the patient at risk for progression?
USA: Mark Stovsky, USA
Europe: Jonathon Olsburgh, UK
17:20-17:40
Early vs. Late initiation of 5α RI
Early: Alexander Greenstein, Israel
Late: Dean Elterman, Canada
17:40-17:50
PSA monitoring during 5α-RI treatment
Prokar Dasgupta, UK
17:50-18:00
Erectile and sexual dysfunction during 5α-RI treatment: Rate, type and management
Ran Katz, Israel 
Session 2
18:00–19:00
Androgen deprivation therapy (ADT)
Chairpersons: Jehonathan Pinthus, Canada & Eliyahu Gez, Israel
18:00-18:20
Agonists vs. antagonists: Is there a winner?
For agonists: Shin Egawa, Japan
For antagonists: E. David Crawford, USA
18:20-18:40
Intermittent treatment: for and against
For: Laurence Klotz, Canada
Against: Mario Eisenberger, USA 
18:40-18:50
The role of FSH
Jehonathan Pinthus, Canada
18:50-19:00
High risk Prostate Cancer: is there a place for preoperative ADT?
Joel Nelson, USA
19:00-19:30
Coffee break and wine drinking
Session 3 19:30-21:00
Honorary Guest Speakers
Chairperson: Jacob Ramon, Israel
 
The 3 P's: Peace, Palestine, Prostate cancer
Mr. Ehud Olmert, Israel
Former Prime Minister of Israel
 
Israel between agreements and crises
Major General (Retired) Amos Yadlin, Israel
Director of Tel Aviv University's Institute for National Security Studies (INSS)
21:00
Get Together